Nucleic Acid Chaperone Activity of HIV-1 Nucleocapsid Protein: Critical Role in Reverse Transcription and Molecular Mechanism

Progress in Nucleic Acid Research and Molecular Biology

Volumn 80, Issue , 2005, Pages 217-286

  Levin, Judith G ^a   Guo, Jianhui ^a   Rouzina, Ioulia ^b   Musier Forsyth, Karin ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b University of Minnesota   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; NUCLEIC ACID; NUCLEOCAPSID PROTEIN; VIRUS DNA; VIRUS RNA; ZINC FINGER PROTEIN;

AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REVERSE TRANSCRIPTION; REVIEW; VIRUS REPLICATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; DNA, VIRAL; HIV-1; HUMANS; MOLECULAR CHAPERONES; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; NUCLEIC ACID CONFORMATION; NUCLEIC ACIDS; NUCLEOCAPSID PROTEINS; REVERSE TRANSCRIPTION; RNA, VIRAL; VIRUS REPLICATION; ZINC FINGERS;

EID: 23144448275     PISSN: 00796603     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6603(05)80006-6     Document Type: Review

References (402)

1. Green L.M., and Berg J.M. Retroviral nucleocapsid protein-metal ion interactions: Folding and sequence variants. Proc. Natl. Acad. Sci. USA 87 (1990) 6403-6407
2. Henderson L.E., Copeland T.D., Sowder R.C., Smythers G.W., and Oroszlan S. Primary structure of the low molecular weight nucleic acid-binding proteins of murine leukemia viruses. J. Biol. Chem. 256 (1981) 8400-8406
3. Berg J.M. Potential metal-binding domains in nucleic acid binding proteins. Science 232 (1986) 485-487
4. Covey S.N. Amino acid sequence homology in gag region of reverse transcribing elements and the coat protein gene of cauliflower mosaic virus. Nucleic Acids Res. 14 (1986) 623-633
5. Darlix J.-L., Lapadat-Tapolsky M., de Rocquigny H., and Roques B.P. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J. Mol. Biol. 254 (1995) 523-537
6. Rein A., Henderson L.E., and Levin J.G. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: Significance for viral replication. Trends Biochem. Sci. 23 (1998) 297-301
7. Coffin J.M., Hughes S.H., and Varmus H.E. "Retroviruses." (1997), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
8. Mervis R.J., et al. The gag gene products of human immunodeficiency virus type 1: Alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors. J. Virol. 62 (1988) 3993-4002
9. Wondrak E.M., Louis J.M., de Rocquigny H., Chermann J.C., and Roques B.P. The gag precursor contains a specific HIV-1 protease cleavage site between the NC (P7) and P1 proteins. FEBS Lett. 333 (1993) 21-24
10. Henderson L.E., et al. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: Posttranslational modifications, proteolytic processings, and complete amino acid sequences. J. Virol. 66 (1992) 1856-1865
11. Darlix J.-L., Gabus C., Nugeyre M.T., Clavel F., and Barré-Sinoussi F. Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J. Mol. Biol. 216 (1990) 689-699
12. Feng Y.X., et al. HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro. Proc. Natl. Acad. Sci. USA 93 (1996) 7577-7581
13. Baba S., et al. Role of the zinc fingers of HIV-1 nucleocapsid protein in maturation of genomic RNA. J. Biochem. 134 (2003) 637-639
14. Sakaguchi K., et al. Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid protein. Proc. Natl. Acad. Sci. USA 90 (1993) 5219-5223
15. Fu W., Gorelick R.J., and Rein A. Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions. J. Virol. 68 (1994) 5013-5018
16. Muriaux D., De Rocquigny H., Roques B.P., and Paoletti J. NCp7 activates HIV-1 Lai RNA dimerization by converting a transient loop-loop complex into a stable dimer. J. Biol. Chem. 271 (1996) 33686-33692
17. Berkowitz R., Fisher J., and Goff S.P. RNA packaging. Curr. Top. Microbiol. Immunol. 214 (1996) 177-218
18. De Rocquigny H., et al. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc. Natl. Acad. Sci. USA 89 (1992) 6472-6476
19. Prats A.C., et al. Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA. EMBO J. 7 (1988) 1777-1783
20. Barat C., et al. HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA. EMBO J. 8 (1989) 3279-3285
21. Lapadat-Tapolsky M., Pernelle C., Borie C., and Darlix J.-L. Analysis of the nucleic acid annealing activities of nucleocapsid protein from HIV-1. Nucleic Acids Res. 23 (1995) 2434-2441
22. Lys in vitro: Studies of viral RNA molecules mutated in regions that flank the primer binding site. J. Virol. 70 (1996) 4996-5004
23. Chan B., Weidemaier K., Yip W.T., Barbara P.F., and Musier-Forsyth K. Intra-tRNA distance measurements for nucleocapsid protein-dependent tRNA unwinding during priming of HIV reverse transcription. Proc. Natl. Acad. Sci. USA 96 (1999) 459-464
24. Feng Y.X., et al. The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: Possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site. J. Virol. 73 (1999) 4251-4256
25. Lys to human immunodeficiency virus type 1 genomic RNA. J. Virol. 73 (1999) 4485-4488
26. Lys.3 and viral RNA template play different roles during initiation of (-) strand DNA reverse transcription. J. Biol. Chem. 276 (2001) 47725-47732
27. Rong L., et al. Roles of the human immunodeficiency virus type 1 nucleocapsid protein in annealing and initiation versus elongation in reverse transcription of viral negative-strand strong-stop DNA. J. Virol. 72 (1998) 9353-9358
28. Iwatani Y., Rosen A.E., Guo J., Musier-Forsyth K., and Levin J.G. Efficient initiation of HIV-1 reverse transcription in vitro. Requirement for RNA sequences downstream of the primer binding site abrogated by nucleocapsid protein-dependent primer-template interactions. J. Biol. Chem. 278 (2003) 14185-14195
29. Cristofari G., and Darlix J.-L. The ubiquitous nature of RNA chaperone proteins. Prog. Nucleic Acid Res. Mol. Biol. 72 (2002) 223-268
30. Lys,3 in the fidelity and efficacy of plus strand DNA transfer during HIV-1 reverse transcription. J. Biol. Chem. 274 (1999) 4412-4420
31. Wu T., Guo J., Bess J., Henderson L.E., and Levin J.G. Molecular requirements for human immunodeficiency virus type 1 plus-strand transfer: Analysis in reconstituted and endogenous reverse transcription systems. J. Virol. 73 (1999) 4794-4805
32. Johnson P.E., et al. A mechanism for plus-strand transfer enhancement by the HIV-1 nucleocapsid protein during reverse transcription. Biochemistry 39 (2000) 9084-9091
33. Muthuswami R., et al. The HIV plus-strand transfer reaction: Determination of replication-competent intermediates and identification of a novel lentiviral element, the primer over-extension sequence. J. Mol. Biol. 315 (2002) 311-323
34. Ji X., Klarmann G.J., and Preston B.D. Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro. Biochemistry 35 (1996) 132-143
35. Wu W., et al. Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. J. Virol. 70 (1996) 7132-7142
36. Drummond J.E., et al. Wild-type and mutant HIV type 1 nucleocapsid proteins increase the proportion of long cDNA transcripts by viral reverse transcriptase. AIDS Res. Hum. Retrovir. 13 (1997) 533-543
37. Klasens B.I., Huthoff H.T., Das A.T., Jeeninga R.E., and Berkhout B. The effect of template RNA structure on elongation by HIV-1 reverse transcriptase. Biochim. Biophys. Acta 1444 (1999) 355-370
38. Zhang W.H., Hwang C.K., Hu W.S., Gorelick R.J., and Pathak V.K. Zinc finger domain of murine leukemia virus nucleocapsid protein enhances the rate of viral DNA synthesis in vivo. J. Virol. 76 (2002) 7473-7484
39. Carteau S., Gorelick R.J., and Bushman F.D. Coupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: Stimulation by the viral nucleocapsid protein. J. Virol. 73 (1999) 6670-6679
40. 2+-dependent DNA integration in vitro. J. Virol. 71 (1997) 6225-6229
41. Gao K., Gorelick R.J., Johnson D.G., and Bushman F. Cofactors for human immunodeficiency virus type 1 cDNA integration in vitro. J. Virol. 77 (2003) 1598-1603
42. Poljak L., et al. Analysis of NCp7-dependent activation of HIV-1 cDNA integration and its conservation among retroviral nucleocapsid proteins. J. Mol. Biol. 329 (2003) 411-421
43. Wu J.Q., et al. Binding of the nucleocapsid protein of type 1 human immunodeficiency virus to nucleic acids studied using phosphorescence and optically detected magnetic resonance. Biochemistry 36 (1997) 12506-12518
44. Urbaneja M.A., Wu M., Casas-Finet J.R., and Karpel R.L. HIV-1 nucleocapsid protein as a nucleic acid chaperone: Spectroscopic study of its helix-destabilizing properties, structural binding specificity, and annealing activity. J. Mol. Biol. 318 (2002) 749-764
45. Fisher R.J., et al. Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides. J. Virol. 72 (1998) 1902-1909
46. Vuilleumier C., et al. Nucleic acid sequence discrimination by the HIV-1 nucleocapsid protein NCp7: A fluorescence study. Biochemistry 38 (1999) 16816-16825
47. Tsuchihashi Z., and Brown P.O. DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 68 (1994) 5863-5870
48. Herschlag D. RNA chaperones and the RNA folding problem. J. Biol. Chem. 270 (1995) 20871-20874
49. Schroeder R., Barta A., and Semrad K. Strategies for RNA folding and assembly. Nat. Rev. Mol. Cell. Biol. 5 (2004) 908-919
50. Bampi C., Jacquenet S., Lener D., Decimo D., and Darlix J.L. The chaperoning and assistance roles of the HIV-1 nucleocapsid protein in proviral DNA synthesis and maintenance. Curr. HIV Res. 2 (2004) 79-92
51. Dib-Hajj F., Khan R., and Giedroc D.P. Retroviral nucleocapsid proteins possess potent nucleic acid strand renaturation activity. Protein Sci. 2 (1993) 231-243
52. Lorsch J.R. RNA chaperones exist and DEAD box proteins get a life. Cell 109 (2002) 797-800
53. Wills J.W., and Craven R.C. Form, function, and use of retroviral Gag proteins. AIDS 5 (1991) 639-654
54. Negroni M., and Buc H. Mechanisms of retroviral recombination. Annu. Rev. Genet. 35 (2001) 275-302
55. Lys in vitro is essentially not specific. J. Biol. Chem. 270 (1995) 1650-1656
56. Berglund J.A., Charpentier B., and Rosbash M. A high affinity binding site for the HIV-1 nucleocapsid protein. Nucleic Acids Res. 25 (1997) 1042-1049
57. D'Souza V., and Summers M.F. Structural basis for packaging the dimeric genome of Moloney murine leukemia virus. Nature 431 (2004) 586-590
58. Amarasinghe G.K., et al. NMR structure of the HIV-1 nucleocapsid protein bound to stem-loop SL2 of the psi-RNA packaging signal. Implications for genome recognition. J. Mol. Biol. 301 (2000) 491-511
59. De Guzman R.N., et al. Structure of the HIV-1 nucleocapsid protein bound to the SL3 Ψ-RNA recognition element. Science 279 (1998) 384-388
60. 2+ HIV-1 nucleocapsid protein are modulated by COOH-terminal processing. J. Biol. Chem. 269 (1994) 22538-22546
61. Karpel R.L., Henderson L.E., and Oroszlan S. Interactions of retroviral structural proteins with single-stranded nucleic acids. J. Biol. Chem. 262 (1987) 4961-4967
62. You J.C., and McHenry C.S. HIV nucleocapsid protein. Expression in Escherichia coli, purification, and characterization. J. Biol. Chem. 268 (1993) 16519-16527
63. Urbaneja M.A., et al. Binding properties of the human immunodeficiency virus type 1 nucleocapsid protein p7 to a model RNA: Elucidation of the structural determinants for function. J. Mol. Biol. 287 (1999) 59-75
64. Lys with HIV-1 nucleocapsid protein. J. Mol. Biol. 306 (2001) 443-454
65. Lys by HIV-1 nucleocapsid protein: Involvement of the zinc fingers and the N-terminal basic extension. Biochimie 85 (2003) 557-561
66. Tisné C., Roques B.P., and Dardel F. The annealing mechanism of HIV-1 reverse transcription primer onto the viral genome. J. Biol. Chem. 279 (2004) 3588-3595
67. Ramboarina S., et al. Effects of temperature on the dynamic behavior of the HIV-1 nucleocapsid NCp7 and its DNA complex. J. Mol. Biol. 316 (2002) 611-627
68. Stote R.H., et al. Structure of the His44 → Ala single point mutant of the distal finger motif of HIV-1 nucleocapsid protein: A combined NMR, molecular dynamics simulation, and fluorescence study. Biochemistry 43 (2004) 7687-7697
69. Shubsda M.F., Paoletti A.C., Hudson B.S., and Borer P.N. Affinities of packaging domain loops in HIV-1 RNA for the nucleocapsid protein. Biochemistry 41 (2002) 5276-5282
70. Cantor C.R., and Schimmel P.R. "Biophysical Chemistry. Part III. The Behavior of Biological Macromolecules," (1980), W. H. Freeman & Co., San Francisco, California
71. Bloomfield V.A., Crothers D.M., and Tinoco Jr. I. "Nucleic Acids: Structures, Properties and Functions." (1998), University Science Press, Mill Valley, California
72. Bloomfield V.A. DNA condensation. Curr. Opinion Struct. Biol. 6 (1996) 334-341
73. Le Cam E., et al. Properties and growth mechanism of the ordered aggregation of a model RNA by the HIV-1 nucleocapsid protein: An electron microscopy investigation. Biopolymers 45 (1998) 217-229
74. Stoylov S.P., et al. Ordered aggregation of ribonucleic acids by the human immunodeficiency virus type 1 nucleocapsid protein. Biopolymers 41 (1997) 301-312
75. Krishnamoorthy G., Roques B., Darlix J.-L., and Mély Y. DNA condensation by the nucleocapsid protein of HIV-1: A mechanism ensuring DNA protection. Nucleic Acids Res. 31 (2003) 5425-5432
76. South T.L., Blake P.R., Hare D.R., and Summers M.F. C-terminal retroviral-type zinc finger domain from the HIV-1 nucleocapsid protein is structurally similar to the N-terminal zinc finger domain. Biochemistry 30 (1991) 6342-6349
77. Summers M.F., South T.L., Kim B., and Hare D.R. High-resolution structure of an HIV zinc fingerlike domain via a new NMR-based distance geometry approach. Biochemistry 29 (1990) 329-340
78. Omichinski J.G., Clore G.M., Sakaguchi K., Appella E., and Gronenborn A.M. Structural characterization of a 39-residue synthetic peptide containing the two zinc binding domains from the HIV-1 p7 nucleocapsid protein by CD and NMR spectroscopy. FEBS Lett. 292 (1991) 25-30
79. Morellet N., et al. Determination of the structure of the nucleocapsid protein NCp7 from the human immunodeficiency virus type 1 by 1H NMR. EMBO J. 11 (1992) 3059-3065
80. Summers M.F., et al. Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci. 1 (1992) 563-574
81. Turner B.G., and Summers M.F. Structural biology of HIV. J. Mol. Biol. 285 (1999) 1-32
82. Chertova E.N., et al. Probing the topography of HIV-1 nucleocapsid protein with the alkylating agent N-ethylmaleimide. Biochemistry 37 (1998) 17890-17897
83. 23 → Cys mutant nucleocapsid protein of HIV-1 indicate that the conformation of the first zinc finger is critical for virus infectivity. Biochemistry 33 (1994) 11707-11716
84. Mély Y., et al. Spatial proximity of the HIV-1 nucleocapsid protein zinc fingers investigated by time-resolved fluorescence and fluorescence resonance energy transfer. Biochemistry 33 (1994) 12085-12091
85. Lee B.M., De Guzman R.N., Turner B.G., Tjandra N., and Summers M.F. Dynamical behavior of the HIV-1 nucleocapsid protein. J. Mol. Biol. 279 (1998) 633-649
86. Lam W.C., et al. Phosphorescence and optically detected magnetic resonance investigation of the binding of the nucleocapsid protein of the human immunodeficiency virus type 1 and related peptides to RNA. Biochemistry 33 (1994) 10693-10700
87. Lam W.C., et al. Evidence for stacking interactions between 5-mercurated polyuridylic acid and HIV-1 p7 nucleocapsid protein obtained by phosphorescence and optically detected magnetic resonance (ODMR). FEBS Lett. 328 (1993) 45-48
88. Mély Y., et al. Influence of the N- and C-terminal chains on the zinc-binding and conformational properties of the central zinc-finger structure of Moloney murine leukemia virus nucleocapsid protein: A steady-state and time-resolved fluorescence study. Biochim. Biophys. Acta 1161 (1993) 6-18
89. Clever J., Sassetti C., and Parslow T.G. RNA secondary structure and binding sites for gag gene products in the 5′ packaging signal of human immunodeficiency virus type 1. J. Virol. 69 (1995) 2101-2109
90. Paoletti A.C., Shubsda M.F., Hudson B.S., and Borer P.N. Affinities of the nucleocapsid protein for variants of SL3 RNA in HIV-1. Biochemistry 41 (2002) 15423-15428
91. Yuan Y., Kerwood D.J., Paoletti A.C., Shubsda M.F., and Borer P.N. Stem of SL1 RNA in HIV-1: Structure and nucleocapsid protein binding for a 1 × 3 internal loop. Biochemistry 42 (2003) 5259-5269
92. Maki A.H., Ozarowski A., Misra A., Urbaneja M.A., and Casas-Finet J.R. Phosphorescence and optically detected magnetic resonance of HIV-1 nucleocapsid protein complexes with stem-loop sequences of the genomic Ψ-recognition element. Biochemistry 40 (2001) 1403-1412
93. Amarasinghe G.K., et al. Stem-loop SL4 of the HIV-1 Ψ RNA packaging signal exhibits weak affinity for the nucleocapsid protein. Structural studies and implications for genome recognition. J. Mol. Biol. 314 (2001) 961-970
94. Hagan N., and Fabris D. Direct mass spectrometric determination of the stoichiometry and binding affinity of the complexes between nucleocapsid protein and RNA stem-loop hairpins of the HIV-1 Ψ-recognition element. Biochemistry 42 (2003) 10736-10745
95. Amarasinghe G.K., De Guzman R.N., Turner R.B., and Summers M.F. NMR structure of stem-loop SL2 of the HIV-1 Ψ RNA packaging signal reveals a novel A-U-A base-triple platform. J. Mol. Biol. 299 (2000) 145-156
96. Maynard A.T., Huang M., Rice W.G., and Covell D.G. Reactivity of the HIV-1 nucleocapsid protein p7 zinc finger domains from the perspective of density-functional theory. Proc. Natl. Acad. Sci. USA 95 (1998) 11578-11583
97. Khandogin J., Musier-Forsyth K., and York D.M. Insights into the regioselectivity and RNA-binding affinity of HIV-1 nucleocapsid protein from linear-scaling quantum methods. J. Mol. Biol. 330 (2003) 993-1004
98. Basrur V., et al. Inactivation of HIV-1 nucleocapsid protein P7 by pyridinioalkanoyl thioesters. Characterization of reaction products and proposed mechanism of action. J. Biol. Chem. 275 (2000) 14890-14897
99. Kohlstaedt L.A., Wang J., Friedman J.M., Rice P.A., and Steitz T.A. Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256 (1992) 1783-1790
100. Jacobo-Molina A., et al. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc. Natl. Acad. Sci. USA 90 (1993) 6320-6324
101. Skalka A.M., and Goff S.P. "Reverse Transcriptase." (1993), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
102. Waters L.C., and Mullin B.C. Transfer RNA in RNA tumor viruses. Prog. Nucleic. Acid. Res. Mol. Biol. 20 (1977) 131-160
103. Lys3 in HIV-1. Curr. HIV Res. 2 (2004) 163-175
104. Marquet R., Isel C., Ehresmann C., and Ehresmann B. tRNAs as primer of reverse transcriptases. Biochimie 77 (1995) 113-124
105. Sawyer R.C., and Hanafusa H. Comparison of the small RNAs of polymerase-deficient and polymerase-positive Rous sarcoma virus and another species of avian retrovirus. J. Virol. 29 (1979) 863-871
106. Peters G.G., and Hu J. Reverse transcriptase as the major determinant for selective packaging of tRNA's into avian sarcoma virus particles. J. Virol. 36 (1980) 692-700
107. Pro during murine leukemia virus assembly. J. Virol. 38 (1981) 403-408
108. Panet A., et al. Specific binding of tryptophan transfer RNA to avian myeloblastosis virus RNA-dependent DNA polymerase reverse transcriptase. Proc. Natl. Acad. Sci. USA 72 (1975) 2535-2539
109. Panet A., Weil G., and Friis R.R. Binding of tryptophanyl-tRNA to the reverse transcriptase of replication-defective avian sarcoma viruses. J. Virol. 28 (1978) 434-443
110. Lys into human immunodeficiency virus type 1 particles. J. Virol. 68 (1994) 2065-2072
111. Cen S., et al. Incorporation of lysyl-tRNA synthetase into human immunodeficiency virus type 1. J. Virol. 75 (2001) 5043-5048
112. Cen S., et al. Retrovirus-specific packaging of aminoacyl-tRNA synthetases with cognate primer tRNAs. J. Virol. 76 (2002) 13111-13115
113. Lys3 aminoacylation and its incorporation into HIV-1. J. Biol. Chem. 277 (2002) 17389-17396
114. Javanbakht H., et al. The interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assembly. J. Biol. Chem. 278 (2003) 27644-27651
115. Lys packaging complex in HIV-1. Int. J. Biochem. Cell Biol. 36 (2004) 1776-1786
116. Prats A.C., et al. Viral RNA annealing activities of the nucleocapsid protein of Moloney murine leukemia virus are zinc independent. Nucleic Acids Res. 19 (1991) 3533-3541
117. Hargittai M.R., Gorelick R.J., Rouzina I., and Musier-Forsyth K. Mechanistic insights into the kinetics of HIV-1 nucleocapsid protein-facilitated tRNA annealing to the primer binding site. J. Mol. Biol. 337 (2004) 951-968
118. Lys,3 structural changes but are not critical for primer/template annealing. J. Mol. Biol. 312 (2001) 985-997
119. Lys primer complex annealed by the nucleocapsid protein: Comparison with the heat-annealed complex. RNA 8 (2002) 8-15
120. Lys. EMBO J. 15 (1996) 917-924
121. Lanchy J.M., Ehresmann C., Le Grice S.F.J., Ehresmann B., and Marquet R. Binding and kinetic properties of HIV-1 reverse transcriptase markedly differ during initiation and elongation of reverse transcription. EMBO J. 15 (1996) 7178-7187
122. Lanchy J.M., et al. Contacts between reverse transcriptase and the primer strand govern the transition from initiation to elongation of HIV-1 reverse transcription. J. Biol. Chem. 273 (1998) 24425-24432
123. Liang C., et al. Mechanistic studies of early pausing events during initiation of HIV-1 reverse transcription. J. Biol. Chem. 273 (1998) 21309-21315
124. Thrall S.H., et al. Pre-steady-state kinetic characterization of RNA-primed initiation of transcription by HIV-1 reverse transcriptase and analysis of the transition to a processive DNA-primed polymerization mode. Biochemistry 37 (1998) 13349-13358
125. Le Grice S.F.J. In the beginning: Initiation of minus strand DNA synthesis in retroviruses and LTR-containing retrotransposons. Biochemistry 42 (2003) 14349-14355
126. Lys (template/primer). J. Mol. Biol. 247 (1995) 236-250
127. Lys. Nucleic Acids Res. 24 (1996) 509-514
128. Khan R., and Giedroc D.P. Recombinant human immunodeficiency virus type 1 nucleocapsid (NCp7) protein unwinds tRNA. J. Biol. Chem. 267 (1992) 6689-6695
129. Lys unwinding in a complex with HIV NCp7. J. Biol. Chem. 272 (1997) 25143-25148
130. Phe: A lead ribozyme and 1H NMR study. Nucleic Acids Res. 24 (1996) 3568-3575
131. Lys modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcription. J. Biol. Chem. 268 (1993) 25269-25272
132. Lys interactions inhibiting primer utilization by retroviral reverse transcriptases. Proc. Natl. Acad. Sci. USA 93 (1996) 10063-10068
133. His. J. Virol. 70 (1996) 966-975
134. Lys/HIV-1 RNA (primer/template) complex. Nucleic Acids Res. 26 (1998) 1198-1204
135. Liang C., et al. The importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity. J. Virol. 71 (1997) 5750-5757
136. Lys anticodon on the initiation of human immunodeficiency virus type 1 reverse transcription. J. Virol. 70 (1996) 4700-4706
137. Met. J. Virol. 71 (1997) 207-217
138. Puglisi E.V., and Puglisi J.D. HIV-1 A-rich RNA loop mimics the tRNA anticodon structure. Nat. Struct. Biol. 5 (1998) 1033-1036
139. Goldschmidt V., et al. Structural variability of the initiation complex of HIV-1 reverse transcription. J. Biol. Chem. 279 (2004) 35923-35931
140. Mal genomes. Nucleic Acids Res. 32 (2004) 4687-4695
141. Goldschmidt V., et al. Direct and indirect contributions of RNA secondary structure elements to the initiation of HIV-1 reverse transcription. J. Biol. Chem. 277 (2002) 43233-43242
142. Trp primer is required for efficient initiation of reverse transcription. J. Virol. 66 (1992) 2464-2472
143. Leis J., Aiyar A., and Cobrinik D. Regulation of initiation of reverse transcription of retroviruses. In: Skalka A.M., and Goff S.P. (Eds). "Reverse Transcriptase" (1993), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York 33-47
144. Trp primer. J. Virol. 76 (2002) 7571-7577
145. Lys,3 with the feline immunodeficiency virus RNA genome governs initiation of minus strand DNA synthesis. J. Biol. Chem. 276 (2001) 27721-27730
146. Beerens N., and Berkhout B. The tRNA primer activation signal in the human immunodeficiency virus type 1 genome is important for initiation and processive elongation of reverse transcription. J. Virol. 76 (2002) 2329-2339
147. Beerens N., Groot F., and Berkhout B. Initiation of HIV-1 reverse transcription is regulated by a primer activation signal. J. Biol. Chem. 276 (2001) 31247-31256
148. Lys during the initiation of reverse transcription?. Nucleic Acids Res. 31 (2003) 850-859
149. Abbink T.E., Beerens N., and Berkhout B. Forced selection of a human immunodeficiency virus type 1 variant that uses a non-self tRNA primer for reverse transcription: Involvement of viral RNA sequences and the reverse transcriptase enzyme. J. Virol. 78 (2004) 10706-10714
150. Arnott S., Chandrasekaran R., Millane R.P., and Park H.S. DNA-RNA hybrid secondary structures. J. Mol. Biol. 188 (1986) 631-640
151. Szyperski T., et al. NMR structure of the chimeric hybrid duplex r(gcaguggc).r(gcca)d(CTGC) comprising the tRNA-DNA junction formed during initiation of HIV-1 reverse transcription. J. Biomol. NMR 13 (1999) 343-355
152. Lanchy J.M., et al. Dynamics of the HIV-1 reverse transcription complex during initiation of DNA synthesis. J. Biol. Chem. 275 (2000) 12306-12312
153. Isel C., et al. Structural basis for the specificity of the initiation of HIV-1 reverse transcription. EMBO J. 18 (1999) 1038-1048
154. Gilboa E., Mitra S.W., Goff S., and Baltimore D. A detailed model of reverse transcription and tests of crucial aspects. Cell 18 (1979) 93-100
155. Luo G.X., and Taylor J. Template switching by reverse transcriptase during DNA synthesis. J. Virol. 64 (1990) 4321-4328
156. Peliska J.A., and Benkovic S.J. Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Science 258 (1992) 1112-1118
157. Telesnitsky A., and Goff S.P. Strong-stop strand transfer during reverse transcription of retroviruses. In: Skalka A.M., and Goff S.P. (Eds). "Reverse Transcriptase" (1993), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York 49-83
158. Berkhout B., and Jeang K.-T. Detailed mutational analysis of TAR RNA: Critical spacing between the bulge and loop recognition domains. Nucleic Acids Res. 19 (1991) 6169-6176
159. Baudin F., et al. Functional sites in the 5′ region of human immunodeficiency virus type 1 RNA form defined structural domains. J. Mol. Biol. 229 (1993) 382-397
160. Panganiban A.T., and Fiore D. Ordered interstrand and intrastrand DNA transfer during reverse transcription. Science 241 (1988) 1064-1069
161. Hu W.S., and Temin H.M. Retroviral recombination and reverse transcription. Science 250 (1990) 1227-1233
162. Jones J.S., Allan R.W., and Temin H.M. One retroviral RNA is sufficient for synthesis of viral DNA. J. Virol. 68 (1994) 207-216
163. van Wamel J.L., and Berkhout B. The first strand transfer during HIV-1 reverse transcription can occur either intramolecularly or intermolecularly. Virology 244 (1998) 245-251
164. Varmus H.E., et al. Kinetics of synthesis, structure, and purification of avian sarcoma virus-specific DNA made in the cytoplasm of acutely infected cells. J. Mol. Biol. 120 (1978) 55-82
165. Fu T.B., and Taylor J. When retroviral reverse transcriptases reach the end of their RNA templates. J. Virol. 66 (1992) 4271-4278
166. Garces J., and Wittek R. Reverse-transcriptase-associated RNaseH activity mediates template switching during reverse transcription in vitro. Proc. R. Soc. Lond. B Biol. Sci. 243 (1991) 235-239
167. Tanese N., Telesnitsky A., and Goff S.P. Abortive reverse transcription by mutants of Moloney murine leukemia virus deficient in the reverse transcriptase-associated RNase H function. J. Virol. 65 (1991) 4387-4397
168. Repaske R., Hartley J.W., Kavlick M.F., O'Neill R.R., and Austin J.B. Inhibition of RNase H activity and viral replication by single mutations in the 3′ region of Moloney murine leukemia virus reverse transcriptase. J. Virol. 63 (1989) 1460-1464
169. Svarovskaia E.S., Delviks K.A., Hwang C.K., and Pathak V.K. Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching. J. Virol. 74 (2000) 7171-7178
170. Hwang C.K., Svarovskaia E.S., and Pathak V.K. Dynamic copy choice: Steady state between murine leukemia virus polymerase and polymerase-dependent RNase H activity determines frequency of in vivo template switching. Proc. Natl. Acad. Sci. USA 98 (2001) 12209-12214
171. Blain S.W., and Goff S.P. Effects on DNA synthesis and translocation caused by mutations in the RNase H domain of Moloney murine leukemia virus reverse transcriptase. J. Virol. 69 (1995) 4440-4452
172. Andersen E.S., Jeeninga R., Damgaard E.C.K., Berkhout B., and Kjems J. Dimerization and template switching in the 5′ untranslated region between various subtypes of human immunodeficiency virus type 1. J. Virol. 77 (2003) 3020-3030
173. Darlix J.-L., Vincent A., Gabus C., de Rocquigny H., and Roques B. Transactivation of the 5′ to 3′ viral DNA strand transfer by nucleocapsid protein during reverse transcription of HIV-1 RNA. C. R. Acad. Sci. Paris Life Sciences 316 (1993) 763-771
174. Peliska J.A., Balasubramanian S., Giedroc D.P., and Benkovic S.J. Recombinant HIV-1 nucleocapsid protein accelerates HIV-1 reverse transcriptase catalyzed DNA strand transfer reactions and modulates RNase H activity. Biochemistry 33 (1994) 13817-13823
175. DeStefano J.J. Human immunodeficiency virus nucleocapsid protein stimulates strand transfer from internal regions of heteropolymeric RNA templates. Arch. Virol. 140 (1995) 1775-1789
176. Rodríguez-Rodríguez L., Tsuchihashi Z., Fuentes G.M., Bambara R.A., and Fay P.J. Influence of human immunodeficiency virus nucleocapsid protein on synthesis and strand transfer by the reverse transcriptase in vitro. J. Biol. Chem. 270 (1995) 15005-15011
177. Kim J.K., Palaniappan C., Wu W., Fay P.J., and Bambara R.A. Evidence for a unique mechanism of strand transfer from the transactivation response region of HIV-1. J. Biol. Chem. 272 (1997) 16769-16777
178. Lapadat-Tapolsky M., Gabus C., Rau M., and Darlix J.-L. Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability. J. Mol. Biol. 268 (1997) 250-260
179. Guo J., Henderson L.E., Bess J., Kane B., and Levin J.G. Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA. J. Virol. 71 (1997) 5178-5188
180. Guo J., Wu T., Bess J., Henderson L.E., and Levin J.G. Actinomycin D inhibits human immunodeficiency virus type 1 minus-strand transfer in in vitro and endogenous reverse transcriptase assays. J. Virol. 72 (1998) 6716-6724
181. Guo J., et al. Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer. J. Virol. 74 (2000) 8980-8988
182. Guo J., et al. Subtle alterations of the native zinc finger structures have dramatic effects on the nucleic acid chaperone activity of human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 76 (2002) 4370-4378
183. Driscoll M.D., Golinelli M.-P., and Hughes S.H. In vitro analysis of human immunodeficiency virus type 1 minus-strand strong-stop DNA synthesis and genomic RNA processing. J. Virol. 75 (2001) 672-686
184. Driscoll M.D., and Hughes S.H. Human immunodeficiency virus type 1 nucleocapsid protein can prevent self-priming of minus-strand strong stop DNA by promoting the annealing of short oligonucleotides to hairpin sequences. J. Virol. 74 (2000) 8785-8792
185. Chen Y., Balakrishnan M., Roques B.P., and Bambara R.A. Steps of the acceptor invasion mechanism for HIV-1 minus strand strong stop transfer. J. Biol. Chem. 278 (2003) 38368-38375
186. Chen Y., Balakrishnan M., Roques B.P., Fay P.J., and Bambara R.A. Mechanism of minus strand strong stop transfer in HIV-1 reverse transcription. J. Biol. Chem. 278 (2003) 8006-8017
187. Derebail S.S., Heath M.J., and DeStefano J.J. Evidence for the differential effects of nucleocapsid protein on strand transfer in various regions of the HIV genome. J. Biol. Chem. 278 (2003) 15702-15712
188. Heilman-Miller S.L., Wu T., and Levin J.G. Alteration of nucleic acid structure and stability modulates the efficiency of minus-strand transfer mediated by the HIV-1 nucleocapsid protein. J. Biol. Chem. 279 (2004) 44154-44165
189. Moscardini M., et al. Functional interactions of nucleocapsid protein of feline immunodeficiency virus and cellular prion protein with the viral RNA. J. Mol. Biol. 318 (2002) 149-159
190. Allain B., Lapadat-Tapolsky M., Berlioz C., and Darlix J.-L. Transactivation of the minus-strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome. EMBO J. 13 (1994) 973-981
191. Allain B., Rascle J.B., de Rocquigny H., Roques B., and Darlix J.-L. CIS elements and trans-acting factors required for minus strand DNA transfer during reverse transcription of the genomic RNA of murine leukemia virus. J. Mol. Biol. 277 (1998) 225-235
192. Rascle J.B., Ficheux D., and Darlix J.-L. Possible roles of nucleocapsid protein of MoMuLV in the specificity of proviral DNA synthesis and in the genetic variability of the virus. J. Mol. Biol. 280 (1998) 215-225
193. Werner S., Vogel-Bachmayr K., Hollinderbaumer B., and Wöhrl B.M. Requirements for minus-strand transfer catalyzed by Rous sarcoma virus reverse transcriptase. J. Virol. 75 (2001) 10132-10138
194. Tanchou V., Gabus C., Rogemond V., and Darlix J.-L. Formation of stable and functional HIV-1 nucleoprotein complexes in vitro. J. Mol. Biol. 252 (1995) 563-571
195. Lapadat-Tapolsky M., et al. Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucleic Acids Res. 21 (1993) 831-839
196. You J.C., and McHenry C.S. Human immunodeficiency virus nucleocapsid protein accelerates strand transfer of the terminally redundant sequences involved in reverse transcription. J. Biol. Chem. 269 (1994) 31491-31495
197. Davis W.R., Gabbara S., Hupe D., and Peliska J.A. Actinomycin D inhibition of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase and nucleocapsid protein. Biochemistry 37 (1998) 14213-14221
198. Hong M.K., et al. Nucleic acid conformational changes essential for HIV-1 nucleocapsid protein-mediated inhibition of self-priming in minus-strand transfer. J. Mol. Biol. 325 (2003) 1-10
199. Golinelli M.-P., and Hughes S.H. Secondary structure in the nucleic acid affects the rate of HIV-1 nucleocapsid-mediated strand annealing. Biochemistry 42 (2003) 8153-8162
200. Williams M.C., et al. Mechanism for nucleic acid chaperone activity of HIV-1 nucleocapsid protein revealed by single molecule stretching. Proc. Natl. Acad. Sci. USA 98 (2001) 6121-6126
201. Williams M.C., Gorelick R.J., and Musier-Forsyth K. Specific zinc-finger architecture required for HIV-1 nucleocapsid protein's nucleic acid chaperone function. Proc. Natl. Acad. Sci. USA 99 (2002) 8614-8619
202. Heath M.J., Derebail S.S., Gorelick R.J., and DeStefano J.J. Differing roles of the N- and C-terminal zinc fingers in human immunodeficiency virus nucleocapsid protein-enhanced nucleic acid annealing. J. Biol. Chem. 278 (2003) 30755-30763
203. Lys with U3 during the first strand transfer of HIV-1 reverse transcription. Nucleic Acids Res. 28 (2000) 634-640
204. Golinelli M.-P., and Hughes S.H. Self-priming of retroviral minus-strand strong-stop DNAs. Virology 285 (2001) 278-290
205. Bernacchi S., et al. HIV-1 nucleocapsid protein activates transient melting of least stable parts of the secondary structure of TAR and its complementary sequence. J. Mol. Biol. 317 (2002) 385-399
206. Beltz H., et al. Impact of the terminal bulges of HIV-1 cTAR DNA on its stability and the destabilizing activity of the nucleocapsid protein NCp7. J. Mol. Biol. 328 (2003) 95-108
207. Oyama F., Kikuchi R., Crouch R.J., and Uchida T. Intrinsic properties of reverse transcriptase in reverse transcription. Associated RNase H is essentially regarded as an endonuclease. J. Biol. Chem. 264 (1989) 18808-18817
208. Schatz O., Mous J., and Le Grice S.F.J. HIV-1 RT-associated ribonuclease H displays both endonuclease and 3′ → 5′ exonuclease activity. EMBO J. 9 (1990) 1171-1176
209. Wöhrl B.M., and Moelling K. Interaction of HIV-1 ribonuclease H with polypurine tract containing RNA-DNA hybrids. Biochemistry 29 (1990) 10141-10147
210. Furfine E.S., and Reardon J.E. Reverse transcriptase•RNase H from the human immunodeficiency virus. Relationship of the DNA polymerase and RNA hydrolysis activities. J. Biol. Chem. 266 (1991) 406-412
211. Lys3-primer excision. Biochemistry 30 (1991) 7041-7046
212. Gopalakrishnan V., Peliska J.A., and Benkovic S.J. Human immunodeficiency virus type 1 reverse transcriptase: Spatial and temporal relationship between the polymerase and RNase H activities. Proc. Natl. Acad. Sci. USA 89 (1992) 10763-10767
213. Post K., et al. A large deletion in the connection subdomain of murine leukemia virus reverse transcriptase or replacement of the RNase H domain with Escherichia coli RNase H results in altered polymerase and RNase H activities. Biochemistry 32 (1993) 5508-5517
214. DeStefano J.J., et al. Polymerization and RNase H activities of the reverse transcriptases from avian myeloblastosis, human immunodeficiency, and Moloney murine leukemia viruses are functionally uncoupled. J. Biol. Chem. 266 (1991) 7423-7431
215. Ben-Artzi H., et al. RNase H activity of reverse transcriptases on substrates derived from the 5′ end of retroviral genome. J. Biol. Chem. 268 (1993) 16465-16471
216. Randolph C.A., and Champoux J.J. The use of DNA and RNA oligonucleotides in hybrid structures with longer polynucleotide chains to probe the structural requirements for Moloney murine leukemia virus plus strand priming. J. Biol. Chem. 269 (1994) 19207-19215
217. Götte M., Maier G., Gross H.J., and Heumann H. Localization of the active site of HIV-1 reverse transcriptase-associated RNase H domain on a DNA template using site-specific generated hydroxyl radicals. J. Biol. Chem. 273 (1998) 10139-10146
218. DeStefano J.J., Mallaber L.M., Fay P.J., and Bambara R.A. Quantitative analysis of RNA cleavage during RNA-directed DNA synthesis by human immunodeficiency and avian myeloblastosis virus reverse transcriptases. Nucleic Acids Res. 22 (1994) 3793-3800
219. Champoux J.J. Roles of ribonuclease H in reverse transcription. In: Skalka A.M., and Goff S.P. (Eds). "Reverse Transcriptase" (1993), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York 103-117
220. DeStefano J.J., Buiser R.G., Mallaber L.M., Bambara R.A., and Fay P.J. Human immunodeficiency virus reverse transcriptase displays a partially processive 3′ to 5′ endonuclease activity. J. Biol. Chem. 266 (1991) 24295-24301
221. Wöhrl B.M., Volkmann S., and Moelling K. Mutations of a conserved residue within HIV-1 ribonuclease H affect its exo- and endonuclease activities. J. Mol. Biol. 220 (1991) 801-818
222. Kati W.M., Johnson K.A., Jerva L.F., and Anderson K.S. Mechanism and fidelity of HIV reverse transcriptase. J. Biol. Chem. 267 (1992) 25988-25997
223. Powell M.D., et al. Residues in the αH and αI helices of the HIV-1 reverse transcriptase thumb subdomain required for the specificity of RNase H-catalyzed removal of the polypurine tract primer. J. Biol. Chem. 274 (1999) 19885-19893
224. Schultz S.J., Zhang M., Kelleher C.D., and Champoux J.J. Polypurine tract primer generation and utilization by Moloney murine leukemia virus reverse transcriptase. J. Biol. Chem. 274 (1999) 34547-34555
225. Wisniewski M., Balakrishnan M., Palaniappan C., Fay P.J., and Bambara R.A. Unique progressive cleavage mechanism of HIV reverse transcriptase RNase H. Proc. Natl. Acad. Sci. USA 97 (2000) 11978-11983
226. Wisniewski M., Balakrishnan M., Palaniappan C., Fay P.J., and Bambara R.A. The sequential mechanism of HIV reverse transcriptase RNase H. J. Biol. Chem. 275 (2000) 37664-37671
227. Wisniewski M., et al. Substrate requirements for secondary cleavage by HIV-1 reverse transcriptase RNase H. J. Biol. Chem. 277 (2002) 28400-28410
228. Palaniappan C., Fuentes G.M., Rodríguez-Rodríguez L., Fay P.J., and Bambara R.A. Helix structure and ends of RNA/DNA hybrids direct the cleavage specificity of HIV-1 reverse transcriptase RNase H. J. Biol. Chem. 271 (1996) 2063-2070
229. DeStefano J.J. The orientation of binding of human immunodeficiency virus reverse transcriptase on nucleic acid hybrids. Nucleic Acids Res. 23 (1995) 3901-3908
230. DeStefano J.J., Cristofaro J.V., Derebail S., Bohlayer W.P., and Fitzgerald-Heath M.J. Physical mapping of HIV reverse transcriptase to the 5′ end of RNA primers. J. Biol. Chem. 276 (2001) 32515-32521
231. Gao H.Q., Sarafianos S.G., Arnold E., and Hughes S.H. RNase H cleavage of the 5′ end of the human immunodeficiency virus type 1 genome. J. Virol. 75 (2001) 11874-11880
232. Cameron C.E., Ghosh M., Le Grice S.F.J., and Benkovic S.J. Mutations in HIV reverse transcriptase which alter RNase H activity and decrease strand transfer efficiency are suppressed by HIV nucleocapsid protein. Proc. Natl. Acad. Sci. USA 94 (1997) 6700-6705
233. Lener D., Tanchou V., Roques B.P., Le Grice S.F.J., and Darlix J.-L. Involvement of HIV-I nucleocapsid protein in the recruitment of reverse transcriptase into nucleoprotein complexes formed in vitro. J. Biol. Chem. 273 (1998) 33781-33786
234. Druillennec S., Caneparo A., de Rocquigny H., and Roques B.P. Evidence of interactions between the nucleocapsid protein NCp7 and the reverse transcriptase of HIV-1. J. Biol. Chem. 274 (1999) 11283-11288
235. Berkhout B., van Wamel J., and Klaver B. Requirements for DNA strand transfer during reverse transcription in mutant HIV-1 virions. J. Mol. Biol. 252 (1995) 59-69
236. Lobel L.I., and Goff S.P. Reverse transcription of retroviral genomes: Mutations in the terminal repeat sequences. J. Virol. 53 (1985) 447-455
237. Ramsey C.A., and Panganiban A.T. Replication of the retroviral terminal repeat sequence during in vivo reverse transcription. J. Virol. 67 (1993) 4114-4121
238. Klaver B., and Berkhout B. Premature strand transfer by the HIV-1 reverse transcriptase during strong-stop DNA synthesis. Nucleic Acids Res. 22 (1994) 137-144
239. Kulpa D., Topping R., and Telesnitsky A. Determination of the site of first strand transfer during Moloney murine leukemia virus reverse transcription and identification of strand transfer-associated reverse transcriptase errors. EMBO J. 16 (1997) 856-865
240. Yin P.D., Pathak V.K., Rowan A.E., Teufel II R.J., and Hu W.-S. Utilization of nonhomologous minus-strand DNA transfer to generate recombinant retroviruses. J. Virol. 71 (1997) 2487-2494
241. Ohi Y., and Clever J.L. Sequences in the 5′ and 3′ R elements of human immunodeficiency virus type 1 critical for efficient reverse transcription. J. Virol. 74 (2000) 8324-8334
242. Dang Q., and Hu W.-S. Effects of homology length in the repeat region on minus-strand DNA transfer and retroviral replication. J. Virol. 75 (2001) 809-820
243. Pfeiffer J.K., and Telesnitsky A. Effects of limiting homology at the site of intermolecular recombinogenic template switching during Moloney murine leukemia virus replication. J. Virol. 75 (2001) 11263-11274
244. Roda R.H., et al. Strand transfer occurs in retroviruses by a pause-initiated two-step mechanism. J. Biol. Chem. 277 (2002) 46900-46911
245. Derebail S.S., and DeStefano J.J. Mechanistic analysis of pause site dependent and independent recombinogenic strand transfer from structurally diverse regions of the HIV genome. J. Biol. Chem. 279 (2004) 47446-47454
246. Negroni M., and Buc H. Copy-choice recombination by reverse transcriptases: Reshuffling of genetic markers mediated by RNA chaperones. Proc. Natl. Acad. Sci. USA 97 (2000) 6385-6390
247. Moumen A., et al. Evidence for a mechanism of recombination during reverse transcription dependent on the structure of the acceptor RNA. J. Biol. Chem. 278 (2003) 15973-15982
248. Galetto R., et al. The structure of HIV-1 genomic RNA in the gp120 gene determines a recombination hot spot in vivo. J. Biol. Chem. 279 (2004) 36625-36632
249. Roda R.H., et al. Role of the reverse transcriptase, nucleocapsid protein, and template structure in the two-step transfer mechanism in retroviral recombination. J. Biol. Chem. 278 (2003) 31536-31546
250. Berkhout B., Vastenhouw N.L., Klasens B.I.F., and Huthoff H. Structural features in the HIV-1 repeat region facilitate strand transfer during reverse transcription. RNA 7 (2001) 1097-1114
251. Heath M.J., and DeStefano J.J. A complementary single-stranded docking site is required for enhancement of strand exchange by human immunodeficiency virus nucleocapsid protein on substrates that model viral recombination. Biochemistry 44 (2005) 3915-3925
252. Zuker M., Mathews D.H., and Turner D.H. Algorithms and thermodynamics for RNA secondary structure prediction: A practical guide. In: Barciszewski J., and Clark B.F.C. (Eds). "RNA Biochemistry and Biotechnology" (1999), Kluwer Academic Publishers, Dordrecht, The Netherlands 11-43
253. Mathews D.H., Sabina J., Zuker M., and Turner D.H. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J. Mol. Biol. 288 (1999) 911-940
254. South T.L., and Summers M.F. Zinc- and sequence-dependent binding to nucleic acids by the N-terminal zinc finger of the HIV-1 nucleocapsid protein: NMR structure of the complex with the Psi-site analog, dACGCC. Protein Sci. 2 (1993) 3-19
255. Morellet N., et al. Structure of the complex between the HIV-1 nucleocapsid protein NCp7 and the single-stranded pentanucleotide d(ACGCC). J. Mol. Biol. 283 (1998) 419-434
256. Balakrishnan M., Fay P.J., and Bambara R.A. The kissing hairpin sequence promotes recombination within the HIV-I 5′ leader region. J. Biol. Chem. 276 (2001) 36482-36492
257. Balakrishnan M., Roques B.P., Fay P.J., and Bambara R.A. Template dimerization promotes an acceptor invasion-induced transfer mechanism during human immunodeficiency virus type 1 minus-strand synthesis. J. Virol. 77 (2003) 4710-4721
258. Telesnitsky A., and Goff S.P. RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template. Proc. Natl. Acad. Sci. USA 90 (1993) 1276-1280
259. Guo J., et al. Defects in primer-template binding, processive DNA synthesis, and RNase H activity associated with chimeric reverse transcriptases having the murine leukemia virus polymerase domain joined to Escherichia coli RNase H. Biochemistry 34 (1995) 5018-5029
260. Dudding L.R., Nkabinde N.C., and Mizrahi V. Analysis of the RNA- and DNA-dependent DNA polymerase activities of point mutants of HIV-1 reverse transcriptase lacking ribonuclease H activity. Biochemistry 30 (1991) 10498-10506
261. DeStefano J.J., Mallaber L.M., Rodríguez-Rodríguez L., Fay P.J., and Bambara R.A. Requirements for strand transfer between internal regions of heteropolymer templates by human immunodeficiency virus reverse transcriptase. J. Virol. 66 (1992) 6370-6378
262. Klarmann G.J., Schauber C.A., and Preston B.D. Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequences in vitro. J. Biol. Chem. 268 (1993) 9793-9802
263. Suo Z., and Johnson K.A. Effect of RNA secondary structure on RNA cleavage catalyzed by HIV-1 reverse transcriptase. Biochemistry 36 (1997) 12468-12476
264. Suo Z., and Johnson K.A. RNA secondary structure switching during DNA synthesis catalyzed by HIV-1 reverse transcriptase. Biochemistry 36 (1997) 14778-14785
265. Harrison G.P., Mayo M.S., Hunter E., and Lever A.M. Pausing of reverse transcriptase on retroviral RNA templates is influenced by secondary structures both 5′ and 3′ of the catalytic site. Nucleic Acids Res. 26 (1998) 3433-3442
266. Post K., et al. Human immunodeficiency virus type 2 reverse transcriptase activity in model systems that mimic steps in reverse transcription. J. Virol. 77 (2003) 7623-7634
267. Messer L.I., et al. Functional analysis of reverse transcription by a frameshift pol mutant of murine leukemia virus. Virology 146 (1985) 146-152
268. Fuentes G.M., Rodríguez-Rodríguez L., Fay P.J., and Bambara R.A. Use of an oligoribonucleotide containing the polypurine tract sequence as a primer by HIV reverse transcriptase. J. Biol. Chem. 270 (1995) 28169-28176
269. Powell M.D., and Levin J.G. Sequence and structural determinants required for priming of plus-strand DNA synthesis by the human immunodeficiency virus type 1 polypurine tract. J. Virol. 70 (1996) 5288-5296
270. Götte M., et al. Temporal coordination between initiation of HIV (+)-strand DNA synthesis and primer removal. J. Biol. Chem. 274 (1999) 11159-11169
271. Schultz S.J., Zhang M., Kelleher C.D., and Champoux J.J. Analysis of plus-strand primer selection, removal, and reutilization by retroviral reverse transcriptases. J. Biol. Chem. 275 (2000) 32299-32309
272. Schultz S.J., Zhang M., and Champoux J.J. Specific cleavages by RNase H facilitate initiation of plus-strand RNA synthesis by Moloney murine leukemia virus. J. Virol. 77 (2003) 5275-5285
273. Rausch J.W., and Le Grice S.F.J. "Binding, bending, and bonding": Polypurine tract-primed initiation of plus-strand DNA synthesis in human immunodeficiency virus. Int. J. Biochem. Cell. Biol. 36 (2004) 1752-1766
274. Powell M.D., et al. Alanine-scanning mutations in the "primer grip" of p66 HIV-1 reverse transcriptase result in selective loss of RNA priming activity. J. Biol. Chem. 272 (1997) 13262-13269
275. Ghosh M., Williams J., Powell M.D., Levin J.G., and Le Grice S.F.J. Mutating a conserved motif of the HIV-1 reverse transcriptase palm subdomain alters primer utilization. Biochemistry 36 (1997) 5758-5768
276. Fedoroff O.Y., Salazar M., and Reid B.R. Structure of a DNA:RNA hybrid duplex. Why RNase H does not cleave pure RNA. J. Mol. Biol. 233 (1993) 509-523
277. Sarafianos S.G., et al. Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J. 20 (2001) 1449-1461
278. Kvaratskhelia M., Budihas S.R., and Le Grice S.F.J. Pre-existing distortions in nucleic acid structure aid polypurine tract selection by HIV-1 reverse transcriptase. J. Biol. Chem. 277 (2002) 16689-16696
279. Charneau P., and Clavel F. A single-stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. J. Virol. 65 (1991) 2415-2421
280. Hungnes O., Tjøtta E., and Grinde B. The plus strand is discontinuous in a subpopulation of unintegrated HIV-1 DNA. Arch. Virol. 116 (1991) 133-141
281. Charneau P., Alizon M., and Clavel F. A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J. Virol. 66 (1992) 2814-2820
282. Hungnes O., Tjøtta E., and Grinde B. Mutations in the central polypurine tract of HIV-1 result in delayed replication. Virology 190 (1992) 440-442
283. Klarmann G.J., Yu H., Chen X., Dougherty J.P., and Preston B.D. Discontinuous plus-strand DNA synthesis in human immunodeficiency virus type 1-infected cells and in a partially reconstituted cell-free system. J. Virol. 71 (1997) 9259-9269
284. Roth M.J., Schwartzberg P.L., and Goff S.P. Structure of the termini of DNA intermediates in the integration of retroviral DNA: Dependence on IN function and terminal DNA sequence. Cell 58 (1989) 47-54
285. Lys residue A58 disrupts reverse transcription and inhibits replication of human immunodeficiency virus type 1. J. Virol. 75 (2001) 9671-9678
286. Ben-Artzi H., et al. Molecular analysis of the second template switch during reverse transcription of the HIV RNA template. Biochemistry 35 (1996) 10549-10557
287. Burnett B.P., and McHenry C.S. Posttranscriptional modification of retroviral primers is required for late stages of DNA replication. Proc. Natl. Acad. Sci. USA 94 (1997) 7210-7215
288. Adachi A., et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59 (1986) 284-291
289. Smith C.M., Smith J.S., and Roth M.J. RNase H requirements for the second strand transfer reaction of human immunodeficiency virus type 1 reverse transcription. J. Virol. 73 (1999) 6573-6581
290. Lys hybrids. J. Mol. Biol. 261 (1996) 315-321
291. Kulkosky J., Katz R.A., and Skalka A.M. Terminal nucleotides of the preintegrative linear form of HIV-1 DNA deduced from the sequence of circular DNA junctions. J. Acquir. Immune Defic. Syndr. 3 (1990) 852-858
292. Smith J.S., Kim S.Y., and Roth M.J. Analysis of long terminal repeat circle junctions of human immunodeficiency virus type 1. J. Virol. 64 (1990) 6286-6290
293. Whitcomb J.M., Kumar R., and Hughes S.H. Sequence of the circle junction of human immunodeficiency virus type 1: Implications for reverse transcription and integration. J. Virol. 64 (1990) 4903-4906
294. Hong T., Drlica K., Pinter A., and Murphy E. Circular DNA of human immunodeficiency virus: Analysis of circle junction nucleotide sequences. J. Virol. 65 (1991) 551-555
295. Pullen K.A., Ishimoto L.K., and Champoux J.J. Incomplete removal of the RNA primer for minus-strand DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase. J. Virol. 66 (1992) 367-373
296. Lys3. J. Biol. Chem. 267 (1992) 15071-15079
297. Schultz S.J., Whiting S.H., and Champoux J.J. Cleavage specificities of Moloney murine leukemia virus RNase H implicated in the second strand transfer during reverse transcription. J. Biol. Chem. 270 (1995) 24135-24145
298. Pro mediated by M-MuLV and HIV-1 reverse transcriptases. Virology 229 (1997) 437-446
299. Trp primer molecule from viral DNA by ribonuclease H during reverse transcription. Cell 30 (1982) 797-805
300. Schatz O., Cromme F.V., Grüninger-Leitch F., and Le Grice S.F.J. Point mutations in conserved amino acid residues within the C-terminal domain of HIV-1 reverse transcriptase specifically repress RNase H function. FEBS Lett. 257 (1989) 311-314
301. Kelleher C.D., and Champoux J.J. Characterization of RNA strand displacement synthesis by Moloney murine leukemia virus reverse transcriptase. J. Biol. Chem. 273 (1998) 9976-9986
302. Fuentes G.M., Fay P.J., and Bambara R.A. Relationship between plus strand DNA synthesis removal of downstream segments of RNA by human immunodeficiency virus, murine leukemia virus, and avian myeloblastoma virus reverse transcriptases. Nucleic Acids Res. 24 (1996) 1719-1726
303. Lanciault C., and Champoux J.J. Single unpaired nucleotides facilitate HIV-1 reverse transcriptase displacement synthesis through duplex RNA. J. Biol. Chem. 279 (2004) 32252-32261
304. Egelé C., et al. HIV-1 nucleocapsid protein binds to the viral DNA initiation sequences and chaperones their kissing interactions. J. Mol. Biol. 342 (2004) 453-466
305. Bebenek K., Abbotts J., Roberts J.D., Wilson S.H., and Kunkel T.A. Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase. J. Biol. Chem. 264 (1989) 16948-16956
306. Huber H.E., McCoy J.M., Seehra J.S., and Richardson C.C. Human immunodeficiency virus 1 reverse transcriptase. Template binding, processivity, strand displacement synthesis, and template switching. J. Biol. Chem. 264 (1989) 4669-4678
307. Williams K.J., Loeb L.A., and Fry M. Synthesis of DNA by human immunodeficiency virus reverse transcriptase is preferentially blocked at template oligo(deoxyadenosine) tracts. J. Biol. Chem. 265 (1990) 18682-18689
308. Ratner L., et al. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313 (1985) 277-284
309. Shinnick T.M., Lerner R.A., and Sutcliffe J.G. Nucleotide sequence of Moloney murine leukaemia virus. Nature 293 (1981) 543-548
310. Bendinelli M., et al. Feline immunodeficiency virus: An interesting model for AIDS studies and an important cat pathogen. Clin. Microbiol. Rev. 8 (1995) 87-112
311. Shank P.R., et al. Mapping unintegrated avian sarcoma virus DNA: Termini of linear DNA bear 300 nucleotides present once or twice in two species of circular DNA. Cell 15 (1978) 1383-1395
312. Collett M.S., Leis J.P., Smith M.S., and Faras A.J. Unwinding-like activity associated with avian retrovirus RNA-directed DNA polymerase. J. Virol. 26 (1978) 498-509
313. Matson S.W., Fay P.J., and Bambara R.A. Mechanism of inhibition of the avian myeloblastosis virus deoxyribonucleic acid polymerase by adriamycin. Biochemistry 19 (1980) 2089-2096
314. Boone L.R., and Skalka A.M. Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. II. Evidence for a strand displacement mechanism in plus-strand synthesis. J. Virol. 37 (1981) 117-126
315. Hottiger M., Podust V.N., Thimmig R.L., McHenry C., and Hübscher U. Strand displacement activity of the human immunodeficiency virus type 1 reverse transcriptase heterodimer and its individual subunits. J. Biol. Chem. 269 (1994) 986-991
316. Fuentes G.M., Rodríguez-Rodríguez L., Palaniappan C., Fay P.J., and Bambara R.A. Strand displacement synthesis of the long terminal repeats by HIV reverse transcriptase. J. Biol. Chem. 271 (1996) 1966-1971
317. Stetor S.R., et al. Characterization of (+) strand initiation and termination sequences located at the center of the equine infectious anemia virus genome. Biochemistry 38 (1999) 3656-3667
318. Hsu T.W., and Taylor J.M. Single-stranded regions on unintegrated avian retrovirus DNA. J. Virol. 44 (1982) 47-53
319. Taylor J.M., Cywinski A., and Smith J.K. Discontinuities in the DNA synthesized by an avian retrovirus. J. Virol. 48 (1983) 654-659
320. Boone L.R., and Skalka A.M. In: Skalka A.M., and Goff S.P. (Eds). "Reverse Transcriptase" (1993), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York 119-133
321. Charneau P., et al. HIV-1 reverse transcription. A termination step at the center of the genome. J. Mol. Biol. 241 (1994) 651-662
322. Hameau L., et al. Human immunodeficiency virus type 1 central DNA flap: Dynamic terminal product of plus-strand displacement DNA synthesis catalyzed by reverse transcriptase assisted by nucleocapsid protein. J. Virol. 75 (2001) 3301-3313
323. Fuentes G.M., Palaniappan C., Fay P.J., and Bambara R.A. Strand displacement synthesis in the central polypurine tract region of HIV-1 promotes DNA to DNA strand transfer recombination. J. Biol. Chem. 271 (1996) 29605-29611
324. Whiting S.H., and Champoux J.J. Strand displacement synthesis capability of Moloney murine leukemia virus reverse transcriptase. J. Virol. 68 (1994) 4747-4758
325. Whiting S.H., and Champoux J.J. Properties of strand displacement synthesis by Moloney murine leukemia virus reverse transcriptase: Mechanistic implications. J. Mol. Biol. 278 (1998) 559-577
326. Winshell J., and Champoux J.J. Structural alterations in the DNA ahead of the primer terminus during displacement synthesis by reverse transcriptases. J. Mol. Biol. 306 (2001) 931-943
327. Berg J.M., and Shi Y. The galvanization of biology: A growing appreciation for the roles of zinc. Science 271 (1996) 1081-1085
328. Zhang Y., and Barklis E. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation. J. Virol. 69 (1995) 5716-5722
329. Méric C., and Spahr P.F. Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging. J. Virol. 60 (1986) 450-459
330. Méric C., Gouilloud E., and Spahr P.F. Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): Deletions of Cys-His boxes. J. Virol. 62 (1988) 3328-3333
331. Méric C., and Goff S.P. Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein. J. Virol. 63 (1989) 1558-1568
332. Gorelick R.J., Henderson L.E., Hanser J.P., and Rein A. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: Evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc. Natl. Acad. Sci. USA 85 (1988) 8420-8424
333. Dupraz P., Oertle S., Méric C., Damay P., and Spahr P.F. Point mutations in the proximal Cys-His box of Rous sarcoma virus nucleocapsid protein. J. Virol. 64 (1990) 4978-4987
334. Gorelick R.J., et al. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J. Virol. 64 (1990) 3207-3211
335. Gorelick R.J., et al. Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: Replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA. J. Virol. 70 (1996) 2593-2597
336. Gorelick R.J., et al. Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: Characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences. Virology 256 (1999) 92-104
337. Gorelick R.J., Chabot D.J., Rein A., Henderson L.E., and Arthur L.O. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J. Virol. 67 (1993) 4027-4036
338. Dorfman T., Luban J., Goff S.P., Haseltine W.A., and Göttlinger H.G. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 67 (1993) 6159-6169
339. Mizuno A., et al. Mutational analysis of two zinc finger motifs in HIV type 1 nucleocapsid proteins: Effects on proteolytic processing of Gag precursors and particle formation. AIDS Res. Hum. Retroviruses 12 (1996) 793-800
340. Bowles N.E., Damay P., and Spahr P.F. Effect of rearrangements and duplications of the Cys-His motifs of Rous sarcoma virus nucleocapsid protein. J. Virol. 67 (1993) 623-631
341. NC results in subtle differences in gag processing and virion maturation associated with degradative loss of mutant NC. J. Virol. 75 (2001) 115-124
342. Tanchou V., et al. Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication. J. Virol. 72 (1998) 4442-4447
343. 2+ fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA. J. Virol. 77 (2003) 1469-1480
344. Berthoux L., Pechoux C., Ottmann M., Morel G., and Darlix J.L. Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis. J. Virol. 71 (1997) 6973-6981
345. Yu Q., and Darlix J.-L. The zinc finger of nucleocapsid protein of Friend murine leukemia virus is critical for proviral DNA synthesis in vivo. J. Virol. 70 (1996) 5791-5798
346. Gorelick R.J., et al. Characterization of the block in replication of nucleocapsid protein zinc finger mutants from Moloney murine leukemia virus. J. Virol. 73 (1999) 8185-8195
347. Lys genomic placement and initiation of reverse transcription in human immunodeficiency virus type 1. J. Virol. 72 (1998) 3907-3915
348. Lys to human immunodeficiency virus type 1 primer binding site is critically dependent on the NCp7 zinc fingers structure. J. Biol. Chem. 273 (1998) 4819-4822
349. Lee N., Gorelick R.J., and Musier-Forsyth K. Zinc finger-dependent HIV-1 nucleocapsid protein-TAR RNA interactions. Nucleic Acids Res. 31 (2003) 4847-4855
350. Ramboarina S., Druillennec S., Morellet N., Bouaziz S., and Roques B.P. Target specificity of human immunodeficiency virus type 1 NCp7 requires an intact conformation of its CCHC N-terminal zinc finger. J. Virol. 78 (2004) 6682-6687
351. Manning G.S. On the application of polyelectrolyte limiting laws to the helix-coil transition of DNA. V. Ionic effects on renaturation kinetics. Biopolymers 15 (1975) 1333-1343
352. Frank-Kamenetskii M.D., Anshelevich A.A., and Lukashin A.V. Polyelectrolyte model of DNA. Sov. Phys. Uspekhi 151 (1987) 595-618
353. Rouzina I., and Bloomfield V.A. Heat capacity effects on the melting of DNA. 1. General aspects. Biophys. J. 77 (1999) 3242-3251
354. Williams M.C., and Rouzina I. Force spectroscopy of single DNA and RNA molecules. Curr. Opin. Struct. Biol. 12 (2002) 330-336
355. Wenner J.R., Williams M.C., Rouzina I., and Bloomfield V.A. Salt dependence of the elasticity and overstretching transition of single DNA molecules. Biophys. J. 82 (2002) 3160-3169
356. Williams M.C., Rouzina I., and Bloomfield V.A. Thermodynamics of DNA interactions from single molecule stretching experiments. Acc. Chem. Res. 35 (2002) 159-166
357. Williams M.C., Wenner J.R., Rouzina I., and Bloomfield V.A. Entropy and heat capacity of DNA melting from temperature dependence of single molecule stretching. Biophys. J. 80 (2001) 1932-1939
358. Williams M.C., Wenner J.R., Rouzina I., and Bloomfield V.A. Effect of pH on the overstretching transition of double-stranded DNA: Evidence of force-induced DNA melting. Biophys. J. 80 (2001) 874-881
359. Smith S.B., Cui Y., and Bustamante C. Overstretching B-DNA: The elastic response of individual double-stranded and single-stranded DNA molecules. Science 271 (1996) 795-799
360. Rouzina I., and Bloomfield V.A. Force-induced melting of the DNA double helix. 2. Effect of solution conditions. Biophys. J. 80 (2001) 894-900
361. Rouzina I., and Bloomfield V.A. Force-induced melting of the DNA double helix 1. Thermodynamic analysis. Biophys. J. 80 (2001) 882-893
362. Azoulay J., Clamme J.P., Darlix J.L., Roques B.P., and Mély Y. Destabilization of the HIV-1 complementary sequence of TAR by the nucleocapsid protein through activation of conformational fluctuations. J. Mol. Biol. 326 (2003) 691-700
363. Beltz H., et al. Role of the structure of the top half of HIV-1 cTAR DNA on the nucleic acid destabilizing activity of the nucleocapsid protein NCp7. J. Mol. Biol. 338 (2004) 711-723
364. Cosa G., et al. Secondary structure and secondary structure dynamics of DNA hairpins complexed with HIV-1 NC protein. Biophys. J. 87 (2004) 2759-2767
365. 2+-dependent conformational change of RNA studied by fluorescence correlation and FRET on immobilized single molecules. Proc. Natl. Acad. Sci. USA 99 (2002) 4284-4289
366. Alberts B.M., and Frey L. T4 bacteriophage gene 32: A structural protein in the replication and recombination of DNA. Nature 227 (1970) 1313-1318
367. Christiansen C., and Baldwin R.L. Catalysis of DNA reassociation by the Escherichia coli DNA binding protein: A polyamine-dependent reaction. J. Mol. Biol. 115 (1977) 441-454
368. Herschlag D., Khosla M., Tsuchihashi Z., and Karpel R.L. An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis. EMBO J. 13 (1994) 2913-2924
369. Pant K., Karpel R.L., Rouzina I., and Williams M.C. Mechanical measurement of single-molecule binding rates: Kinetics of DNA helix-destabilization by T4 gene 32 protein. J. Mol. Biol. 336 (2004) 851-870
370. Wetmur J.G., and Davidson N. Kinetics of renaturation of DNA. J. Mol. Biol. 31 (1968) 349-370
371. Wetmur J.G. Hybridization and renaturation kinetics of nucleic acids. Annu. Rev. Biophys. Bioeng. 5 (1976) 337-361
372. Wetmur J.G. DNA probes: Applications of the principles of nucleic acid hybridization. CRC Crit. Rev. Biochem. Mol. Biol. 26 (1991) 227-259
373. Reynaldo L.P., Vologodskii A.V., Neri B.P., and Lyamichev V.I. The kinetics of oligonucleotide replacements. J. Mol. Biol. 297 (2000) 511-520
374. Pontius B.W., and Berg P. Renaturation of complementary DNA strands mediated by purified mammalian heterogeneous nuclear ribonucleoprotein A1 protein: Implications for a mechanism for rapid molecular assembly. Proc. Natl. Acad. Sci. USA 87 (1990) 8403-8407
375. Pontius B.W., and Berg P. Rapid renaturation of complementary DNA strands mediated by cationic detergents: A role for high-probability binding domains in enhancing the kinetics of molecular assembly processes. Proc. Natl. Acad. Sci. USA 88 (1991) 8237-8241
376. Pontius B.W., and Berg P. Rapid assembly and disassembly of complementary DNA strands through an equilibrium intermediate state mediated by A1 hnRNP protein. J. Biol. Chem. 267 (1992) 13815-13818
377. Kumar A., and Wilson S.H. Studies of the strand-annealing activity of mammalian hnRNP complex protein A1. Biochemistry 29 (1990) 10717-10722
378. Homann M., Nedbal W., and Sczakiel G. Dissociation of long-chain duplex RNA can occur via strand displacement in vitro: Biological implications. Nucleic Acids Res. 24 (1996) 4395-4400
379. Nedbal W., Frey M., Willemann B., Zentgraf H., and Sczakiel G. Mechanistic insights into p53-promoted RNA-RNA annealing. J. Mol. Biol. 266 (1997) 677-687
380. Nedbal W., Homann M., and Sczakiel G. The association of complementary ribonucleic acids can be strongly increased without lowering Arrhenius activation energies or significantly altering structures. Biochemistry 36 (1997) 13552-13557
381. Windbichler N., Werner M., and Schroeder R. Kissing complex-mediated dimerization of HIV-1 RNA: Coupling extended duplex formation to ribozyme cleavage. Nucleic Acids Res. 31 (2003) 6419-6427
382. Lai E., and van Zanten J.H. Monitoring DNA/poly-L-lysine polyplex formation with time-resolved multiangle laser light scattering. Biophys. J. 80 (2001) 864-873
383. Nguyen T.T., and Shklovskii B.I. Kinetics of macroion coagulation induced by multivalent counterions. Phys. Rev. E. Stat. Nonlin. Soft Matter Phys. 65 (2002) 1-7
384. Craig M.E., Crothers D.M., and Doty P. Relaxation kinetics of dimer formation by self complementary oligonucleotides. J. Mol. Biol. 62 (1971) 383-401
385. Kozyavkin S.A., Mirkin S.M., and Amirikyan B.R. The ionic strength dependence of the cooperativity factor for DNA melting. J. Biomolec. Struct. Dynam. 5 (1987) 119-126
386. Kallenbach N.R., Crothers D.M., and Mortimer R.G. Interpretation of the kinetics of helix formation. Biochem. Biophys. Res. Commun. 11 (1963) 213-216
387. Sikorav J.L., and Church G.M. Complementary recognition in condensed DNA: Accelerated DNA renaturation. J. Mol. Biol. 222 (1991) 1085-1108
388. Gabus C., et al. The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein. J. Mol. Biol. 307 (2001) 1011-1021
389. Gabus C., et al. The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCp7 of HIV-1. J. Biol. Chem. 276 (2001) 19301-19309
390. Matulis D., Rouzina I., and Bloomfield V.A. Thermodynamics of cationic lipid binding to DNA and DNA condensation: Roles of electrostatics and hydrophobicity. J. Am. Chem. Soc. 124 (2002) 7331-7342
391. Pontius B.W. Close encounters: Why unstructured, polymeric domains can increase rates of specific macromolecular association. Trends Biochem. Sci. 18 (1993) 181-186
392. Rouzina I., and Bloomfield V.A. Macroion attraction due to electrostatic correlation between screening counterions. 1. Mobile surface-adsorbed ions and diffuse ion cloud. J. Phys. Chem. 100 (1996) 9977-9989
393. Nguyen T.T., Rouzina I., and Shklovskii B.I. Reentrant condensation of DNA induced by multivalent counterions. J. Chem. Phys. 112 (2000) 2562-2568
394. Heilman-Miller S.L., Thirumalai D., and Woodson S.A. Role of counterion condensation in folding of the Tetrahymena ribozyme. I. Equilibrium stabilization by cations. J. Mol. Biol. 306 (2001) 1157-1166
395. Heilman-Miller S.L., Pan J., Thirumalai D., and Woodson S.A. Role of counterion condensation in folding of the Tetrahymena ribozyme. II. Counterion-dependence of folding kinetics. J. Mol. Biol. 309 (2001) 57-68
396. Koculi E., Lee N.K., Thirumalai D., and Woodson S.A. Folding of the Tetrahymena ribozyme by polyamines: Importance of counterion valence and size. J. Mol. Biol. 341 (2004) 27-36
397. Jeeninga R.E., Huthoff H.T., Gultyaev A.P., and Berkhout B. The mechanism of actinomycin D-mediated inhibition of HIV-1 reverse transcription. Nucleic Acids Res. 26 (1998) 5472-5479
398. Imamichi T., et al. Actinomycin D induces high-level resistance to thymidine analogs in replication of human immunodeficiency virus type 1 by interfering with host cell thymidine kinase expression. J. Virol. 77 (2003) 1011-1020
399. Rice W.G., et al. Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science 270 (1995) 1194-1197
400. Gabbara S., Davis W.R., Hupe L., Hupe D., and Peliska J.A. Inhibitors of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Biochemistry 38 (1999) 13070-13076
401. Davis W.R., et al. Inhibition of HIV-1 reverse transcriptase-catalyzed DNA strand transfer reactions by 4-chlorophenylhydrazone of mesoxalic acid. Biochemistry 39 (2000) 14279-14291
402. Lifson J.D., et al. Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins. AIDS Res. Hum. Retroviruses 20 (2004) 772-787